Healthcare


 Institutional Ownership in Australian Clinical Labs Limited (ASX:ACL)

Institutional Ownership in Australian Clinical Labs Limited (ASX:ACL)

February 27, 2025 04:26 PM AEDT| By Team Kalkine Media

Highlights,Institutional investors hold a significant stake in Australian Clinical Labs, shaping its strategic direction.,The largest shareholders include a mix of institutions, hedge funds, and company insiders.,The general public also holds a subst...

 EZZ Life Science Holdings: Financial Performance and Leadership Insight

EZZ Life Science Holdings: Financial Performance and Leadership Insight

February 27, 2025 01:39 PM AEDT| By Team Kalkine Media

Highlights:,Earnings per share for EZZ Life Science Holdings has shown consistent growth.,Company leadership holds a significant portion of shares, reinforcing confidence.,CEO's remuneration remains aligned with financial performance and company dire...

 Ownership Structure of Integral Diagnostics and Its Market Influence

Ownership Structure of Integral Diagnostics and Its Market Influence

February 27, 2025 01:37 PM AEDT| By Team Kalkine Media

Highlights:,Individual investors control the largest portion of Integral Diagnostics' shares.,Institutional ownership reflects significant interest in the company.,Private companies and insiders hold smaller stakes in the business.,Integral Diagnosti...

 Should You Be Concerned About CleanSpace Holdings' (ASX:CSX) Debt Despite the Lack of Earnings?

Should You Be Concerned About CleanSpace Holdings' (ASX:CSX) Debt Despite the Lack of Earnings?

February 27, 2025 01:32 PM AEDT| By Team Kalkine Media

Highlights:,CleanSpace Holdings maintains more liquid assets than liabilities, with a strong cash position.,The company reports steady revenue growth, reflecting an expanding market presence.,A net cash balance underscores financial stability, reduci...

 Neuren Pharmaceuticals Reports Record Sales Growth for Rett Syndrome Drug

Neuren Pharmaceuticals Reports Record Sales Growth for Rett Syndrome Drug

February 27, 2025 12:21 PM AEDT| By Team Kalkine Media

Highlights,Neuren,Pharmaceuticals (NEU) sees a 97% surge in full-year sales for Rett syndrome drug DAYBUE™.,Acadia Pharmaceuticals (,NASDAQ:ACAD,) reports record quarterly and full-year sales in the US.,Forecasted royalties for,Neuren,Pharmaceuticals...

 Monash IVF Group (ASX:MVF) Delivers Strong Performance with Double-Digit Revenue Growth in 1H25

Monash IVF Group (ASX:MVF) Delivers Strong Performance with Double-Digit Revenue Growth in 1H25

February 27, 2025 12:09 PM AEDT| By Team Kalkine Media

Highlights,Revenue surged 11.6% to $140.3 million in the first half of 2025.,Underlying,NPAT increased by 5.5% to $15.8 million,Expanding fertility services with new specialists and infrastructure projects.,Monash IVF Group (ASX:MVF) has reported a s...

 AnteoTech's impressive performance in the first half of FY2025 paves the way for future growth.

AnteoTech's impressive performance in the first half of FY2025 paves the way for future growth.

February 27, 2025 11:00 AM AEDT| By Team Kalkine Media

Highlights,AnteoTech reports a 74% increase in revenue driven by strategic commercial initiatives.,Significant progress noted in Clean Energy and Life Sciences sectors, with key partnerships enhancing growth.,The company's financial strategies includ...

 Neuren Shares See Half-Price Discount as Brokers Sound the Alarm

Neuren Shares See Half-Price Discount as Brokers Sound the Alarm

February 27, 2025 11:00 AM AEDT| By Team Kalkine Media

Highlights,Neuren Pharmaceuticals (ASX:NEU) sees potential leveraged growth for its Rett syndrome drug, Daybue.,February's biotech sector downturn offers opportunities for investment research as major stocks face price corrections.,Dimerix (ASX:DXB)...

 What's Happening with Actinogen’s Xanamem in 2025?

What's Happening with Actinogen’s Xanamem in 2025?

February 27, 2025 10:30 AM AEDT| By Team Kalkine Media

Highlights,The biotechnology sector is driving advancements in neurological disorder treatments, with a focus on Alzheimer’s disease.,Actinogen Medical has received an international non-proprietary name for Xanamem, marking a key regulatory milestone...

 Nanosonics Limited Reports Strong Earnings and Cash Flow Performance

Nanosonics Limited Reports Strong Earnings and Cash Flow Performance

February 26, 2025 07:31 PM AEDT| By Team Kalkine Media

Highlights:,Nanosonics Limited demonstrates strong earnings growth in its latest financial update.,The company’s free cash flow surpasses reported profits, reflecting efficient cash management.,Earnings per share have shown significant improvement ov...

 If the Liberals secure victory in the WA election, anticipate significant changes in the mining sector, beginning with a substantial reduction in red tape.

If the Liberals secure victory in the WA election, anticipate significant changes in the mining sector, beginning with a substantial reduction in red tape.

February 26, 2025 04:31 PM AEDT| By Team Kalkine Media

Highlights,Political debates intensify over mining policies ahead of WA elections.,Proposed reforms could impact regulations, land access, and labor markets.,Industry stakeholders watch closely as policies evolve.,The mining and resources sector is a...

 Recce Pharmaceuticals Expands Global Reach with Japanese Patent Approval

Recce Pharmaceuticals Expands Global Reach with Japanese Patent Approval

February 26, 2025 01:59 PM AEDT| By Team Kalkine Media

Highlights,Recce Pharmaceuticals (RCE) secures a new patent in Japan, extending protection until 2041.,Japan’s pharmaceutical market ranks third globally, with rising demand for anti-infective therapies.,Patent covers RECCE® 327 and RECCE® 529, targe...

 Sonic Healthcare's (ASX:SHL) First Half 2025 Results Show Steady Growth and Margin Expansion

Sonic Healthcare's (ASX:SHL) First Half 2025 Results Show Steady Growth and Margin Expansion

February 26, 2025 01:53 PM AEDT| By Team Kalkine Media

Highlights,Revenue reaches AU$4.67 billion, marking an 8.4% increase year-over-year.,Net income rises 17% to AU$236.7 million, improving profit margins.,Revenue growth projections align with industry trends in Australia.,f 2025, demonstrating steady...

 PolyNovo (ASX:PNV) Reports First Half 2025 Financial Results

PolyNovo (ASX:PNV) Reports First Half 2025 Financial Results

February 26, 2025 01:39 PM AEDT| By Team Kalkine Media

Highlights,Revenue increases by 26% compared to 1H 2024,Profit margin slightly decreases to 5.6%,EPS improves from AU$0.004 to AU$0.005,PolyNovo (,ASX:PNV,) has released its first half 2025 financial results, showcasing a strong growth in revenues. T...

 AI platform Decidr partners with Go1 to enhance corporate learning

AI platform Decidr partners with Go1 to enhance corporate learning

February 26, 2025 11:00 AM AEDT| By Team Kalkine Media

Highlights,Decidr Industries (ASX:DAI) partners with Go1 to enhance AI-driven career development solutions.,The partnership aims to integrate Decidr’s AI technology into Go1’s extensive learning platform, offering customized upskilling and career pat...

 Regis Healthcare Limited: Sustained Growth and Market Performance

Regis Healthcare Limited: Sustained Growth and Market Performance

February 25, 2025 03:30 PM AEDT| By Team Kalkine Media

Highlights:,Consistent Revenue Expansion:,Growth trends play a crucial role in shaping market valuation.,Dividend Impact on Returns:,Shareholder returns are significantly influenced by dividend distributions.,Market Performance Trends:,Share price mo...

 Steady Dividend Growth: Sonic Healthcare (ASX:SHL) Enhances Shareholder Returns

Steady Dividend Growth: Sonic Healthcare (ASX:SHL) Enhances Shareholder Returns

February 25, 2025 01:58 PM AEDT| By Team Kalkine Media

Highlights,Sonic Healthcare (SHL) to distribute a dividend of A$0.44 per share.,Attractive,yield of 3.8% enhances shareholder returns.,Consistent 10-year history of steady dividend growth.,Sonic Healthcare (ASX:SHL) has announced an upcoming dividend...

 Earnings Surge and Valuation Concerns: A Closer Look at PolyNovo’s Performance

Earnings Surge and Valuation Concerns: A Closer Look at PolyNovo’s Performance

February 25, 2025 01:56 PM AEDT| By Team Kalkine Media

Highlights,PolyNovo,(,ASX:PNOV,) shares,drop,14.7% in early trading.,First-half results show a,strong,increase in net profit and revenue.,Revised forecasts reflect challenges from currency and market pressures.,PolyNovo (ASX:PNOV), a leading medical...

 Cryosite's First Half 2025 Financials: A Detailed Look

Cryosite's First Half 2025 Financials: A Detailed Look

February 25, 2025 01:37 PM AEDT| By Team Kalkine Media

Highlights,Cryosite's revenue rises 3.7% to AU$6.64m.,Net income remains steady at AU$838.0k.,Shares increase by 14% in the past week.,The recent financial release by Cryosite (ASX:CTE) for the first half of 2025 reveals a 3.7% increase in revenue, a...

 Nanosonics Limited (ASX:NAN): A Closer Look at Recent Stock Activity

Nanosonics Limited (ASX:NAN): A Closer Look at Recent Stock Activity

February 25, 2025 01:37 PM AEDT| By Team Kalkine Media

Highlights,Nanosonics shares surge 26% in the past month,The company's P/S ratio stands at 7.7x, above industry norms,Future revenue growth aligns closely with industry expectations,Nanosonics Limited, with the ticker (ASX:NAN), has experienced a rem...

AU_advertise

Advertise your brand on Kalkine Media

Recent Articles






Investing Tips

Previous Next
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.